Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Researchers develop first implanted device to treat balance disorder

October 21, 2010 By EurekAlert

A University of Washington Medical Center patient on Thursday,
Oct. 21, will be the world’s first recipient of a device that aims
to quell the disabling vertigo associated with Meniere’s
disease.

The UW Medicine clinicians who developed the implantable device
hope that success in a 10-person surgical trial of Meniere’s
patients will lead to exploration of its usefulness against other
common balance disorders that torment millions of people
worldwide.

The device being tested a cochlear implant and processor with
re-engineered software and electrode arrays represents four-plus
years of work by Drs. Jay Rubinstein and James Phillips of UW’s
Department of Otolaryngology-Head and Neck Surgery. They worked
with Drs. Steven Bierer, Albert Fuchs, Chris Kaneko, Leo Ling and
Kaibao Nie, UW specialists in signal processing, brainstem
physiology and vestibular neural coding.

“What we’re proposing here is a potentially safer and more
effective therapy than exists now,” said Rubinstein, an ear surgeon
and auditory scientist who has earned a doctoral degree in
bioengineering and who holds multiple U.S. patents.

In the United States, Meniere’s affects less than one percent of
the population. The disease occurs mostly in people between ages 30
and 50, but can strike anyone. Patients more often experience the
condition in one ear; about 30 percent of cases are bilateral.

The disease affects hearing and balance with varying intensity
and frequency but can be extremely debilitating. Its episodic
attacks are thought to stem from the rupture of an inner-ear
membrane. Endolymphatic fluid leaks out of the vestibular system,
causing havoc to the brain’s perception of balance.

To stave off nausea, afflicted people must lie still, typically
for several hours and sometimes up to half a day while the membrane
self-repairs and equilibrium is restored, said Phillips, a UW
research associate professor and director of the UW Dizziness and
Balance Center. Because the attacks come with scant warning, a
Meniere’s diagnosis can cause people to change careers and curb
their lifestyles.

Many patients respond to first-line treatments of medication and
changes to diet and activity. When those therapies fail to reduce
the rate of attacks, surgery is often an effective option but it
typically is ablative (destructive) in nature. In essence, the
patient sacrifices function in the affected ear to halt the vertigo
akin to a pilot who shuts down an erratic engine during flight.
Forever after, the person’s balance and, often, hearing are based
on one ear’s function.

With their device, Phillips and Rubinstein aim to restore the
patient’s balance during attacks while leaving natural hearing and
residual balance function intact.

A patient wears a processor behind the affected ear and
activates it as an attack starts. The processor wirelessly signals
the device, which is implanted almost directly underneath in a
small well created in the temporal bone. The device in turn
transmits electrical impulses through three electrodes inserted
into the canals of the inner ear’s bony labyrinth.

“It’s an override,” Phillips said. “It doesn’t change what’s
happening in the ear, but it eliminates the symptoms while
replacing the function of that ear until it recovers.”

The specific placement of the electrodes in the bony labyrinth
is determined by neuronal signal testing at the time of implant.
The superior semicircular canal, lateral semicircular canal and
posterior semicircular canal each receive one electrode array.

A National Institutes of Health grant funded the development of
the device and its initial testing at the Washington National
Primate Research Center. The promising results from those tests led
the U.S. Food and Drug Administration, in June, to approve the
device and the proposed surgical implantation procedure. Shortly
thereafter, the limited surgical trial in humans won approval from
the Western Institutional Review Board, an independent body charged
with protecting the safety of research subjects.

By basing their invention on cochlear implants whose design and
surgical implantation were already FDA-approved, Phillips and
Rubinstein leapfrogged scientists at other institutions who had
begun years earlier but chosen to develop novel prototypes.

“If you started from scratch, in a circumstance like this where
no one has ever treated a vestibular disorder with a device, it
probably would take 10 years to develop such a device,” Rubinstein
said.

The device epitomizes the translational advancements pursued at
UW’s academic medical centers, he said. He credited the team’s
skills and its access to the primate center, whose labs facilitated
the quick turnaround of results that helped win the FDA’s
support.

A successful human trial could lead the implant to become the
first-choice surgical intervention for Meniere’s patients, Phillips
said, and spark collaboration with other researchers who are
studying more widespread balance disorders.

The first patient will be a 56-year-old man from Yakima, Wash.
He has unilateral Meniere’s disease and has been a patient of
Rubinstein’s for about two years.

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 13, 2022
Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech